← Back to Search

Tailored Risk Reduction Strategies for Preventable Causes of Death

N/A

Waitlist Available

Led By Ronald S Braithwaite, Braithwaite

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to month 12

Awards & highlights

Study Summary

This trial will study if a tailored approach can help reduce risks of death from preventable causes, like heart attacks, strokes, drinking, drug use, HIV, etc.

Who is the study for?

This trial is for people aged 35-64 with low income (≤ $38,000), at high risk of heart disease (10-year risk ≥10%), and who drink heavily based on SAMHSA's definition. Participants must be willing to use New York's public health system and can consent in English or Spanish.Check my eligibility

What is being tested?

The study tests a personalized intervention aimed at reducing death from preventable causes like heart disease, excessive alcohol use, substance abuse, and HIV. It includes patient outreach navigation, individualized health benefits personalization, and covering patients' health-related costs.See study design

What are the potential side effects?

Since this trial focuses on behavioral interventions rather than medications, traditional side effects are not applicable. However, participants may experience stress or discomfort discussing personal habits related to alcohol consumption and substance use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in 2-Week Timeline Follow-Back (TLFB) for Alcohol Use

Change in Alcohol Use Disorders Identification Test (AUDIT) Score

Change in Alcohol Use Disorders Identification Test-Concise (AUDIT-C)

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Low SES Population - InterventionExperimental Treatment1 Intervention

Participants receive the study intervention, composed of navigation, compensation, and personalization for study participants. The intervention will be administered in person to the participants recruited for the study and will be administered by peer navigators who will be trained on Motivational Interviewing (MINT) techniques.

Group II: Low SES Population - No InterventionActive Control1 Intervention

Participants receive no intervention components of navigation, compensation, and personalization. Participants will receive their normal medical care through regular doctor visits without any intervention or personalization.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,448 Total Patients Enrolled

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

802 Previous Clinical Trials

1,365,295 Total Patients Enrolled

Ronald S Braithwaite, BraithwaitePrincipal InvestigatorNYU Langone Health

Media Library

Low SES Population - Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05828849 — N/A

Substance Use Disorder Research Study Groups: Low SES Population - No Intervention, Low SES Population - Intervention

Substance Use Disorder Clinical Trial 2023: Low SES Population - Intervention Highlights & Side Effects. Trial Name: NCT05828849 — N/A

Low SES Population - Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05828849 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies open to participants in this trial?

"Data found on clinicaltrials.gov indicates that this particular trial is not currently recruiting patients, even though it was most recently updated in April of 2023. Fortunately, there are 1965 other trials for which recruitment is actively underway."

Answered by AI

Is this research project accommodating participants older than thirty years?

"Prospective participants must meet the age requirement of 35 years old or younger and 64 years old or older in order to be eligible for this clinical trial."

Answered by AI

Is there an opportunity for me to take part in this research endeavor?

"Those hoping to be part of this trial should have a diagnosed form of alcoholism and must lie within the age bracket 35-64. Additionally, 150 participants are required for successful completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

2024. "Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05828849.